MAIN ALAN J

CIK 00012273721 companyTHE WOODLANDS, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001227372

Recent Transactions

50 trades

Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2025-02-28+25,667→ 281,391 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2025-02-28−25,667→ 0 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2025-02-28+32,904→ 314,295 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2025-02-28+68,243→ 382,538 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2025-02-28−32,904→ 32,903 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2025-02-28$0.67/sh−43,434→ 339,104 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2025-02-28−68,243→ 136,487 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2025-02-13+502,060→ 502,060 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2025-02-13+753,090→ 753,090 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28$2.62/sh−24,408→ 255,724 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-28−25,666→ 25,667 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28+25,666→ 247,229 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28+8,977→ 221,563 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28+32,903→ 280,132 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-28−32,903→ 65,807 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-28−8,977→ 0 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2024-02-08+204,730→ 204,730 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-08+204,730→ 204,730 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-28−25,667→ 51,333 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-02-28+25,667→ 233,532 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-02-28+8,976→ 207,865 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-28−8,976→ 8,977 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-28−23,300→ 0 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-02-28+23,300→ 198,889 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-02-28$2.17/sh−20,946→ 212,586 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-09+98,710→ 98,710 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2023-02-09+296,130→ 296,130 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2022-02-28−23,300→ 23,300 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-02-28+23,300→ 186,368 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2022-02-28−8,977→ 17,953 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2022-02-28−22,373→ 0 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-02-28$2.85/sh−19,756→ 175,589 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-02-28+8,977→ 195,345 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-02-28+22,373→ 163,068 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2022-02-10+77,000→ 77,000 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2022-02-10+230,990→ 230,990 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−8,297→ 0 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−22,374→ 22,373 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−2,497→ 0 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−23,300→ 46,600 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+23,300→ 161,108 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28$7.19/sh−20,413→ 140,695 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+22,374→ 137,808 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+8,297→ 115,434 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+2,497→ 107,137 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2021-02-11+80,780→ 80,780 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-11+26,930→ 26,930 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-04-22+19,893→ 111,453 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-04-22$1.96/sh−6,813→ 104,640 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-02-28+8,296→ 81,946 total

Companies

LEXICON PHARMACEUTICALS, INC.
EVP, Pharmaceutical Research
$LXRX

Recent Filings

Address

8800 TECHNOLOGY FOREST PLACE

THE WOODLANDS, TX, 773811160

View on SEC.gov